Zdrowie i gospodarka · 05/04/2017
FDA Hosts Public Workshop on Antibody Mediated Rejection in Kidney Transplantation
The FDA is hosting a public workshop to gather input from various stakeholders on new developments and scientific issues related to antibody mediated rejection in kidney transplantation, with the goal of informing future discussions on clinical trial design and endpoints for prophylaxis and treatment of AMR in kidney transplant recipients.